Breast Carcinoma
|
2793
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.100 |
0.941 |
17 |
2012 |
2020 |
Malignant neoplasm of breast
|
3417
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.100 |
0.941 |
17 |
2012 |
2020 |
Malignant Neoplasms
|
1641
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.100 |
0.909 |
11 |
2013 |
2020 |
Primary malignant neoplasm
|
1374
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.100 |
0.909 |
11 |
2013 |
2020 |
Colorectal Carcinoma
|
1962
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.100 |
0.900 |
10 |
2012 |
2020 |
Malignant neoplasm of colon and/or rectum
|
502
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.060 |
0.833 |
6 |
2012 |
2020 |
Malignant neoplasm of stomach
|
615
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.060 |
0.833 |
6 |
2010 |
2019 |
Stomach Carcinoma
|
652
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.060 |
0.833 |
6 |
2010 |
2019 |
Carcinogenesis
|
355
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
0.667 |
3 |
2012 |
2019 |
Carcinoma of lung
|
1204
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
0.667 |
3 |
2015 |
2017 |
Diabetes Mellitus
|
824
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
0.333 |
3 |
2016 |
2019 |
Diabetes Mellitus, Non-Insulin-Dependent
|
2672
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
1.000 |
3 |
2013 |
2016 |
Malignant neoplasm of lung
|
1142
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
0.667 |
3 |
2015 |
2017 |
Non-Small Cell Lung Carcinoma
|
712
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
1.000 |
3 |
2012 |
2015 |
Primary malignant neoplasm of lung
|
981
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
0.667 |
3 |
2015 |
2017 |
Diabetes
|
710
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.020 |
0.500 |
2 |
2016 |
2019 |
Stomach Neoplasms
|
55
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.020 |
0.500 |
2 |
2019 |
2020 |
Adult Diffuse Large B-Cell Lymphoma
|
46
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2020 |
2020 |
Atrial Septal Defects
|
96
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Breast Cancer, Familial
|
91
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2010 |
2010 |
cervical cancer
|
268
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Cervix carcinoma
|
283
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Coronary heart disease
|
1178
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2019 |
2019 |
Diffuse Large B-Cell Lymphoma
|
127
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2020 |
2020 |
Esophageal carcinoma
|
272
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
|
1 |
2017 |
2017 |